Nanobiotix S.A.
NANO.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €27 | -€21 | €9 | €33 |
| % Growth | 227.5% | -325% | -71.8% | – |
| Cost of Goods Sold | €0 | €0 | €0 | -€3 |
| Gross Profit | €27 | -€21 | €9 | €33 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | €15 | €19 | €22 | €21 |
| G&A Expenses | €0 | €20 | €0 | €0 |
| SG&A Expenses | €11 | €10 | €11 | €11 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €0 | -€4 | €0 | €3 |
| Operating Expenses | €26 | €24 | €33 | €34 |
| Operating Income | €1 | -€45 | -€24 | -€1 |
| % Margin | 3% | 214.1% | -254.6% | -4.3% |
| Other Income/Exp. Net | -€6 | -€2 | €2 | -€10 |
| Pre-Tax Income | -€5 | -€46 | -€22 | -€11 |
| Tax Expense | €0 | -€0 | €0 | €0 |
| Net Income | -€5 | -€46 | -€22 | -€12 |
| % Margin | -20.2% | 221.4% | -235.5% | -35.2% |
| EPS | -0.11 | -0.98 | -0.46 | -0.31 |
| % Growth | 88.8% | -113% | -48.4% | – |
| EPS Diluted | -0.11 | -0.98 | -0.46 | -0.3 |
| Weighted Avg Shares Out | 47 | 47 | 47 | 38 |
| Weighted Avg Shares Out Dil | 47 | 47 | 47 | 39 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €3 | €1 | €1 |
| Interest Expense | €4 | €8 | €4 | €4 |
| Depreciation & Amortization | €0 | €0 | €0 | €1 |
| EBITDA | €1 | -€44 | -€23 | -€5 |
| % Margin | 4.1% | 212.6% | -250.2% | -15% |